These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The effect of fluconazole on circulating ethinyl estradiol levels in women taking oral contraceptives. Sinofsky FE; Pasquale SA Am J Obstet Gynecol; 1998 Feb; 178(2):300-4. PubMed ID: 9500490 [TBL] [Abstract][Full Text] [Related]
23. Formation of ethinyl estradiol in women during treatment with norethindrone acetate. Chu MC; Zhang X; Gentzschein E; Stanczyk FZ; Lobo RA J Clin Endocrinol Metab; 2007 Jun; 92(6):2205-7. PubMed ID: 17341557 [TBL] [Abstract][Full Text] [Related]
24. Glucose and insulin levels after six months of treatment with a triphasic oral contraceptive containing ethinyl estradiol and norethindrone. Spellacy WN; Ellingson AB; Tsibris JC J Reprod Med; 1989 Aug; 34(8):540-2. PubMed ID: 2681750 [TBL] [Abstract][Full Text] [Related]
25. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives. Kojima T; Lindheim SR; Duffy DM; Vijod MA; Stanczyk FZ; Lobo RA Am J Obstet Gynecol; 1993 Dec; 169(6):1540-4. PubMed ID: 8267059 [TBL] [Abstract][Full Text] [Related]
26. The pharmacokinetic interaction between an oral contraceptive containing ethinyl estradiol and norethindrone and the HCV protease inhibitor telaprevir. Garg V; van Heeswijk R; Yang Y; Kauffman R; Smith F; Adda N J Clin Pharmacol; 2012 Oct; 52(10):1574-83. PubMed ID: 22039291 [TBL] [Abstract][Full Text] [Related]
27. Prospective study of carbohydrate metabolism in women using a triphasic oral contraceptive containing norethindrone and ethinyl estradiol for 3 months. Spellacy WN; Ellingson AB; Kotlik A; Tsibris JC Am J Obstet Gynecol; 1988 Oct; 159(4):877-9. PubMed ID: 3052079 [TBL] [Abstract][Full Text] [Related]
28. Ethinyl estradiol and norethindrone radioimmunoassay following Sephadex LH-20 column chromatography. Zacur HA; Linkins S; Chang V; Smith B; Kimball AW; Burkman R Clin Chim Acta; 1991 Dec; 204(1-3):209-15. PubMed ID: 1819463 [No Abstract] [Full Text] [Related]
29. Simultaneous determination of norethindrone and ethinyl estradiol in human plasma by high performance liquid chromatography with tandem mass spectrometry--experiences on developing a highly selective method using derivatization reagent for enhancing sensitivity. Li W; Li YH; Li AC; Zhou S; Naidong W J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Oct; 825(2):223-32. PubMed ID: 16213451 [TBL] [Abstract][Full Text] [Related]
31. Metabolism of oral contraceptive drugs. The formation and disappearance of metabolites of norethindrone and mestranol after intravenous and oral administration. Mills TM; Lin TJ; Braselton WE; Ellegood JO; Mahesh VB Am J Obstet Gynecol; 1976 Dec; 126(8):987-92. PubMed ID: 998688 [TBL] [Abstract][Full Text] [Related]
32. Interaction of rifampicin treatment with pharmacokinetics and metabolism of ethinyloestradiol in man. Bolt HM; Bolt M; Kappus H Acta Endocrinol (Copenh); 1977 May; 85(1):189-197. PubMed ID: 577076 [TBL] [Abstract][Full Text] [Related]
33. A multicenter randomized comparison of cycle control and laboratory findings with oral contraceptive agents containing 100 microg levonorgestrel with 20 microg ethinyl estradiol or triphasic norethindrone with ethinyl estradiol. Reisman H; Martin D; Gast MJ Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 2):45-52. PubMed ID: 10561675 [TBL] [Abstract][Full Text] [Related]
34. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins. Goldzieher JW; de la Peña A; Chenault CB; Cervantes A Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928 [TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of norethindrone oenanthate in 5 women after a single dose of norethindrone oenanthate and estradiol valerate. Sang GW; Liu XH Zhongguo Yao Li Xue Bao; 1986 May; 7(3):255-9. PubMed ID: 2954375 [No Abstract] [Full Text] [Related]
36. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles. Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353 [TBL] [Abstract][Full Text] [Related]
37. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive. Barditch-Crovo P; Trapnell CB; Ette E; Zacur HA; Coresh J; Rocco LE; Hendrix CW; Flexner C Clin Pharmacol Ther; 1999 Apr; 65(4):428-38. PubMed ID: 10223781 [TBL] [Abstract][Full Text] [Related]
38. Absorption of an oestrogen-progestogen preparation. Staland B Maturitas; 1983 Aug; 5(2):85-8. PubMed ID: 6633271 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetic interaction between ethinyl estradiol, norethindrone and darunavir with low-dose ritonavir in healthy women. Sekar VJ; Lefebvre E; Guzman SS; Felicione E; De Pauw M; Vangeneugden T; Hoetelmans RM Antivir Ther; 2008; 13(4):563-9. PubMed ID: 18672535 [TBL] [Abstract][Full Text] [Related]
40. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids. Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]